This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,254.16 firm fixed-price delivery order is for the supply of XEOMIN 100 unit vials, with a period of performance through December 6, 2024.
The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award did not utilize any set-aside designations, indicating open competition. There is no information provided about major subcontractors. This contract supports the DLA's role in supplying medical products to federal government agencies, particularly military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 2/13/25, 9:12 AM